Scholarlink

<p>Phage endolysins are considered promising novel antimicrobial agents capable of inducing rapid bacterial lysis through efficient degradation of peptidoglycan layers in the cell wall. In this study, the endolysin-encoding gene <i>Lys40</i> from <i>Salmonella</i> phage SP_4 was subjected to comprehensive bioinformatic analysis. The results indicated that Lys40 contains eight α-helices and two β-strands, belongs to the lyz_endolysin_autolysin domain family (residues 10–147), and lacks both a signal peptide and transmembrane regions. A recombinant expression system was constructed using the <i>pET28b(+)</i> vector and <i>Escherichia coli</i> BL21 (DE3), enabling successful soluble expression of Lys40. Antimicrobial assays demonstrated that, when combined with the permeabilizer EDTA, Lys40 exhibited significant lytic activity not only against <i>Salmonella</i> but also toward <i>E. coli.</i> The observed synergistic antibacterial effect of Lys40 combined with EDTA in this study provides experimental data support for the development of novel antimicrobial agents.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Prokaryotic Expression and Preliminary Application of Lys40, an Endolysin from Broad-Host-Range Salmonella enterica Phage SP_4

  • 期刊论文

  • 发表日期：

    2026年4月20日

查看全文
  • Zhichuang Huo,
  • Ziqiang Xie,
  • Yanze He,
  • Jinzhe Kang,
  • Shasha Feng,
  • Zhihui Chang,
  • Jing Zhang,
  • Tianyi Sun,
  • Cuihong Zhong,
  • Yuxiang Shi,
  • Yongying Zhang

摘要

Phage endolysins are considered promising novel antimicrobial agents capable of inducing rapid bacterial lysis through efficient degradation of peptidoglycan layers in the cell wall. In this study, the endolysin-encoding gene Lys40 from Salmonella phage SP_4 was subjected to comprehensive bioinformatic analysis. The results indicated that Lys40 contains eight α-helices and two β-strands, belongs to the lyz_endolysin_autolysin domain family (residues 10–147), and lacks both a signal peptide and transmembrane regions. A recombinant expression system was constructed using the pET28b(+) vector and Escherichia coli BL21 (DE3), enabling successful soluble expression of Lys40. Antimicrobial assays demonstrated that, when combined with the permeabilizer EDTA, Lys40 exhibited significant lytic activity not only against Salmonella but also toward E. coli. The observed synergistic antibacterial effect of Lys40 combined with EDTA in this study provides experimental data support for the development of novel antimicrobial agents.